Dan M. Watkins

Aclaris Life Sciences, Inc. operates as a technology-based company which focuses on rational drug design to identify novel drugs for cancer and chronic inflammatory diseases. It also engages in design and development of kinase inhibitors that target key enzymes involved in the regulation of cancer growth, survival and metastasis in modulations of chronic inflammation. The company was founded by Joseph B. Monahan, Gabriel Mbalaviele and Shaun R. Selness in 2010 and is headquartered in St. Louis, MO.

Aclaris Life Sciences, Inc. operates as a technology-based company which focuses on rational drug design to identify novel drugs for cancer and chronic inflammatory diseases. It also engages in design and development of kinase inhibitors that target key enzymes involved in the regulation of cancer growth, survival and metastasis in modulations of chronic inflammation. The company was founded by Joseph B. Monahan, Gabriel Mbalaviele and Shaun R. Selness in 2010 and is headquartered in St. Louis, MO.

Resonant Therapeutics, Inc. operates as a life science company that focuses on generating novel targets relevant to in vivo tumor biology with unprecedented speed. The company was founded by John K. Westwick and Stephen J. Weiss in 2014 and is headquartered in Houston, TX.

DNAtrix, Inc. operates as a biotech company which focuses on the development of oncolytic viruses for cancer. The firm’s offers DNX-2401 product which is an oncolytic virus designed specifically for treating Glioblastoma. It also works to expand its platform technology for treating other cancers, including ovarian, prostate and pancreatic cancer indications. The company was founded in 2005 by Francis Patrick McCormick, Alfred Yung, Charles Conrad, Cande Gomez-Manzano and Juan Fueyo and is headquartered in Houston, TX.

Aclaris Life Sciences, Inc. operates as a technology-based company which focuses on rational drug design to identify novel drugs for cancer and chronic inflammatory diseases. It also engages in design and development of kinase inhibitors that target key enzymes involved in the regulation of cancer growth, survival and metastasis in modulations of chronic inflammation. The company was founded by Joseph B. Monahan, Gabriel Mbalaviele and Shaun R. Selness in 2010 and is headquartered in St. Louis, MO.

Olea Networks, Inc. engages in the provision of technology services. It offers Olea Edge Analytics, a solution to optimize water delivery, billing, and conservation. The company was founded in August 2014 and is headquartered in Austin, TX.

Mercury Partners Management LLC (Mercury Partners) is a venture capital subsidiary of Threshold Ventures Inc. founded in 2005 by Dan Watkins and Blair Garrou. The firm is headquartered in Houston, Texas.

Mercury Partners Management LLC (Mercury Partners) is a venture capital subsidiary of Threshold Ventures Inc. founded in 2005 by Dan Watkins and Blair Garrou. The firm is headquartered in Houston, Texas.

Mercury Partners Management LLC (Mercury Partners) is a venture capital subsidiary of Threshold Ventures Inc. founded in 2005 by Dan Watkins and Blair Garrou. The firm is headquartered in Houston, Texas.

Aclaris Life Sciences, Inc. operates as a technology-based company which focuses on rational drug design to identify novel drugs for cancer and chronic inflammatory diseases. It also engages in design and development of kinase inhibitors that target key enzymes involved in the regulation of cancer growth, survival and metastasis in modulations of chronic inflammation. The company was founded by Joseph B. Monahan, Gabriel Mbalaviele and Shaun R. Selness in 2010 and is headquartered in St. Louis, MO.

Mercury Partners Management LLC (Mercury Partners) is a venture capital subsidiary of Threshold Ventures Inc. founded in 2005 by Dan Watkins and Blair Garrou. The firm is headquartered in Houston, Texas.

Glycos Biotechnologies, Inc. operates as a biochemical company which commercializes sustainable chemicals made from renewable feed stocks. It offers Lactic acid, Isoprene and Butadiene products. It also offers metabolic engineering and process development technology solutions. The company was founded by Ramon Y. Gonzalez and Syed Shams Yazdani in February 2007 and is headquartered in Houston, TX.

Aclaris Life Sciences, Inc. operates as a technology-based company which focuses on rational drug design to identify novel drugs for cancer and chronic inflammatory diseases. It also engages in design and development of kinase inhibitors that target key enzymes involved in the regulation of cancer growth, survival and metastasis in modulations of chronic inflammation. The company was founded by Joseph B. Monahan, Gabriel Mbalaviele and Shaun R. Selness in 2010 and is headquartered in St. Louis, MO.

Aclaris Life Sciences, Inc. operates as a technology-based company which focuses on rational drug design to identify novel drugs for cancer and chronic inflammatory diseases. It also engages in design and development of kinase inhibitors that target key enzymes involved in the regulation of cancer growth, survival and metastasis in modulations of chronic inflammation. The company was founded by Joseph B. Monahan, Gabriel Mbalaviele and Shaun R. Selness in 2010 and is headquartered in St. Louis, MO.

Mercury Partners Management LLC (Mercury Partners) is a venture capital subsidiary of Threshold Ventures Inc. founded in 2005 by Dan Watkins and Blair Garrou. The firm is headquartered in Houston, Texas.

Mercury Partners Management LLC (Mercury Partners) is a venture capital subsidiary of Threshold Ventures Inc. founded in 2005 by Dan Watkins and Blair Garrou. The firm is headquartered in Houston, Texas.

DNAtrix, Inc. operates as a biotech company which focuses on the development of oncolytic viruses for cancer. The firm’s offers DNX-2401 product which is an oncolytic virus designed specifically for treating Glioblastoma. It also works to expand its platform technology for treating other cancers, including ovarian, prostate and pancreatic cancer indications. The company was founded in 2005 by Francis Patrick McCormick, Alfred Yung, Charles Conrad, Cande Gomez-Manzano and Juan Fueyo and is headquartered in Houston, TX.

Aclaris Life Sciences, Inc. operates as a technology-based company which focuses on rational drug design to identify novel drugs for cancer and chronic inflammatory diseases. It also engages in design and development of kinase inhibitors that target key enzymes involved in the regulation of cancer growth, survival and metastasis in modulations of chronic inflammation. The company was founded by Joseph B. Monahan, Gabriel Mbalaviele and Shaun R. Selness in 2010 and is headquartered in St. Louis, MO.

DNAtrix, Inc. operates as a biotech company which focuses on the development of oncolytic viruses for cancer. The firm’s offers DNX-2401 product which is an oncolytic virus designed specifically for treating Glioblastoma. It also works to expand its platform technology for treating other cancers, including ovarian, prostate and pancreatic cancer indications. The company was founded in 2005 by Francis Patrick McCormick, Alfred Yung, Charles Conrad, Cande Gomez-Manzano and Juan Fueyo and is headquartered in Houston, TX.

Mercury Partners Management LLC (Mercury Partners) is a venture capital subsidiary of Threshold Ventures Inc. founded in 2005 by Dan Watkins and Blair Garrou. The firm is headquartered in Houston, Texas.

Mercury Partners Management LLC (Mercury Partners) is a venture capital subsidiary of Threshold Ventures Inc. founded in 2005 by Dan Watkins and Blair Garrou. The firm is headquartered in Houston, Texas.

BioHouston, Inc. engages in life science and biotechnology commercialization. The firm's mission is to create an environment that will stimulate technology transfer and research commercialization, thereby generating economic wealth for the Houston region and making it a global competitor in life science commercialization. The company is headquartered in Houston, TX.

Olea Networks, Inc. engages in the provision of technology services. It offers Olea Edge Analytics, a solution to optimize water delivery, billing, and conservation. The company was founded in August 2014 and is headquartered in Austin, TX.

DNAtrix, Inc. operates as a biotech company which focuses on the development of oncolytic viruses for cancer. The firm’s offers DNX-2401 product which is an oncolytic virus designed specifically for treating Glioblastoma. It also works to expand its platform technology for treating other cancers, including ovarian, prostate and pancreatic cancer indications. The company was founded in 2005 by Francis Patrick McCormick, Alfred Yung, Charles Conrad, Cande Gomez-Manzano and Juan Fueyo and is headquartered in Houston, TX.

Mercury Partners Management LLC (Mercury Partners) is a venture capital subsidiary of Threshold Ventures Inc. founded in 2005 by Dan Watkins and Blair Garrou. The firm is headquartered in Houston, Texas.

Mercury Partners Management LLC (Mercury Partners) is a venture capital subsidiary of Threshold Ventures Inc. founded in 2005 by Dan Watkins and Blair Garrou. The firm is headquartered in Houston, Texas.

BioHouston, Inc. engages in life science and biotechnology commercialization. The firm's mission is to create an environment that will stimulate technology transfer and research commercialization, thereby generating economic wealth for the Houston region and making it a global competitor in life science commercialization. The company is headquartered in Houston, TX.

Mercury Partners Management LLC (Mercury Partners) is a venture capital subsidiary of Threshold Ventures Inc. founded in 2005 by Dan Watkins and Blair Garrou. The firm is headquartered in Houston, Texas.

Mercury Partners Management LLC (Mercury Partners) is a venture capital subsidiary of Threshold Ventures Inc. founded in 2005 by Dan Watkins and Blair Garrou. The firm is headquartered in Houston, Texas.

Mercury Partners Management LLC (Mercury Partners) is a venture capital subsidiary of Threshold Ventures Inc. founded in 2005 by Dan Watkins and Blair Garrou. The firm is headquartered in Houston, Texas.

Mercury Partners Management LLC (Mercury Partners) is a venture capital subsidiary of Threshold Ventures Inc. founded in 2005 by Dan Watkins and Blair Garrou. The firm is headquartered in Houston, Texas.

Mercury Partners Management LLC (Mercury Partners) is a venture capital subsidiary of Threshold Ventures Inc. founded in 2005 by Dan Watkins and Blair Garrou. The firm is headquartered in Houston, Texas.

Courier Therapeutics, Inc. is a company based in Houston, TX. Courier Therapeutics, Inc. specializes in courier therapeutics. The company was founded by Dan M. Watkins, who has been the CEO since incorporation. Courier Therapeutics was acquired by Valo Health LLC on July 27, 2021.

Courier Therapeutics, Inc. is a company based in Houston, TX. Courier Therapeutics, Inc. specializes in courier therapeutics. The company was founded by Dan M. Watkins, who has been the CEO since incorporation. Courier Therapeutics was acquired by Valo Health LLC on July 27, 2021.

Olea Networks, Inc. engages in the provision of technology services. It offers Olea Edge Analytics, a solution to optimize water delivery, billing, and conservation. The company was founded in August 2014 and is headquartered in Austin, TX.

BioHouston, Inc. engages in life science and biotechnology commercialization. The firm's mission is to create an environment that will stimulate technology transfer and research commercialization, thereby generating economic wealth for the Houston region and making it a global competitor in life science commercialization. The company is headquartered in Houston, TX.

Mercury Partners Management LLC (Mercury Partners) is a venture capital subsidiary of Threshold Ventures Inc. founded in 2005 by Dan Watkins and Blair Garrou. The firm is headquartered in Houston, Texas.

Mercury Partners Management LLC (Mercury Partners) is a venture capital subsidiary of Threshold Ventures Inc. founded in 2005 by Dan Watkins and Blair Garrou. The firm is headquartered in Houston, Texas.

Mercury Partners Management LLC (Mercury Partners) is a venture capital subsidiary of Threshold Ventures Inc. founded in 2005 by Dan Watkins and Blair Garrou. The firm is headquartered in Houston, Texas.

Mercury Partners Management LLC (Mercury Partners) is a venture capital subsidiary of Threshold Ventures Inc. founded in 2005 by Dan Watkins and Blair Garrou. The firm is headquartered in Houston, Texas.

Mercury Partners Management LLC (Mercury Partners) is a venture capital subsidiary of Threshold Ventures Inc. founded in 2005 by Dan Watkins and Blair Garrou. The firm is headquartered in Houston, Texas.

BioHouston, Inc. engages in life science and biotechnology commercialization. The firm's mission is to create an environment that will stimulate technology transfer and research commercialization, thereby generating economic wealth for the Houston region and making it a global competitor in life science commercialization. The company is headquartered in Houston, TX.

Mercury Partners Management LLC (Mercury Partners) is a venture capital subsidiary of Threshold Ventures Inc. founded in 2005 by Dan Watkins and Blair Garrou. The firm is headquartered in Houston, Texas.

Mercury Partners Management LLC (Mercury Partners) is a venture capital subsidiary of Threshold Ventures Inc. founded in 2005 by Dan Watkins and Blair Garrou. The firm is headquartered in Houston, Texas.

Aclaris Life Sciences, Inc. operates as a technology-based company which focuses on rational drug design to identify novel drugs for cancer and chronic inflammatory diseases. It also engages in design and development of kinase inhibitors that target key enzymes involved in the regulation of cancer growth, survival and metastasis in modulations of chronic inflammation. The company was founded by Joseph B. Monahan, Gabriel Mbalaviele and Shaun R. Selness in 2010 and is headquartered in St. Louis, MO.

BioHouston, Inc. engages in life science and biotechnology commercialization. The firm's mission is to create an environment that will stimulate technology transfer and research commercialization, thereby generating economic wealth for the Houston region and making it a global competitor in life science commercialization. The company is headquartered in Houston, TX.

BioHouston, Inc. engages in life science and biotechnology commercialization. The firm's mission is to create an environment that will stimulate technology transfer and research commercialization, thereby generating economic wealth for the Houston region and making it a global competitor in life science commercialization. The company is headquartered in Houston, TX.

BioHouston, Inc. engages in life science and biotechnology commercialization. The firm's mission is to create an environment that will stimulate technology transfer and research commercialization, thereby generating economic wealth for the Houston region and making it a global competitor in life science commercialization. The company is headquartered in Houston, TX.

Mercury Partners Management LLC (Mercury Partners) is a venture capital subsidiary of Threshold Ventures Inc. founded in 2005 by Dan Watkins and Blair Garrou. The firm is headquartered in Houston, Texas.

Olea Networks, Inc. engages in the provision of technology services. It offers Olea Edge Analytics, a solution to optimize water delivery, billing, and conservation. The company was founded in August 2014 and is headquartered in Austin, TX.

BioHouston, Inc. engages in life science and biotechnology commercialization. The firm's mission is to create an environment that will stimulate technology transfer and research commercialization, thereby generating economic wealth for the Houston region and making it a global competitor in life science commercialization. The company is headquartered in Houston, TX.

Sinopsys Surgical, Inc. provides medical devices and instruments to evaluate potential new surgical procedures for the treatment of sinusitis. It offers instruments for surgical procedure for the lacrimal glands. The company was founded by Harry Ross in 2011 and is headquartered in Boulder, CO.

Glycos Biotechnologies, Inc. operates as a biochemical company which commercializes sustainable chemicals made from renewable feed stocks. It offers Lactic acid, Isoprene and Butadiene products. It also offers metabolic engineering and process development technology solutions. The company was founded by Ramon Y. Gonzalez and Syed Shams Yazdani in February 2007 and is headquartered in Houston, TX.

Olea Networks, Inc. engages in the provision of technology services. It offers Olea Edge Analytics, a solution to optimize water delivery, billing, and conservation. The company was founded in August 2014 and is headquartered in Austin, TX.

BioHouston, Inc. engages in life science and biotechnology commercialization. The firm's mission is to create an environment that will stimulate technology transfer and research commercialization, thereby generating economic wealth for the Houston region and making it a global competitor in life science commercialization. The company is headquartered in Houston, TX.

BioHouston, Inc. engages in life science and biotechnology commercialization. The firm's mission is to create an environment that will stimulate technology transfer and research commercialization, thereby generating economic wealth for the Houston region and making it a global competitor in life science commercialization. The company is headquartered in Houston, TX.

Glycos Biotechnologies, Inc. operates as a biochemical company which commercializes sustainable chemicals made from renewable feed stocks. It offers Lactic acid, Isoprene and Butadiene products. It also offers metabolic engineering and process development technology solutions. The company was founded by Ramon Y. Gonzalez and Syed Shams Yazdani in February 2007 and is headquartered in Houston, TX.

BioHouston, Inc. engages in life science and biotechnology commercialization. The firm's mission is to create an environment that will stimulate technology transfer and research commercialization, thereby generating economic wealth for the Houston region and making it a global competitor in life science commercialization. The company is headquartered in Houston, TX.

BioHouston, Inc. engages in life science and biotechnology commercialization. The firm's mission is to create an environment that will stimulate technology transfer and research commercialization, thereby generating economic wealth for the Houston region and making it a global competitor in life science commercialization. The company is headquartered in Houston, TX.

BioHouston, Inc. engages in life science and biotechnology commercialization. The firm's mission is to create an environment that will stimulate technology transfer and research commercialization, thereby generating economic wealth for the Houston region and making it a global competitor in life science commercialization. The company is headquartered in Houston, TX.

BioHouston, Inc. engages in life science and biotechnology commercialization. The firm's mission is to create an environment that will stimulate technology transfer and research commercialization, thereby generating economic wealth for the Houston region and making it a global competitor in life science commercialization. The company is headquartered in Houston, TX.

DNAtrix, Inc. operates as a biotech company which focuses on the development of oncolytic viruses for cancer. The firm’s offers DNX-2401 product which is an oncolytic virus designed specifically for treating Glioblastoma. It also works to expand its platform technology for treating other cancers, including ovarian, prostate and pancreatic cancer indications. The company was founded in 2005 by Francis Patrick McCormick, Alfred Yung, Charles Conrad, Cande Gomez-Manzano and Juan Fueyo and is headquartered in Houston, TX.

Glycos Biotechnologies, Inc. operates as a biochemical company which commercializes sustainable chemicals made from renewable feed stocks. It offers Lactic acid, Isoprene and Butadiene products. It also offers metabolic engineering and process development technology solutions. The company was founded by Ramon Y. Gonzalez and Syed Shams Yazdani in February 2007 and is headquartered in Houston, TX.

Mercury Partners Management LLC (Mercury Partners) is a venture capital subsidiary of Threshold Ventures Inc. founded in 2005 by Dan Watkins and Blair Garrou. The firm is headquartered in Houston, Texas.

BioHouston, Inc. engages in life science and biotechnology commercialization. The firm's mission is to create an environment that will stimulate technology transfer and research commercialization, thereby generating economic wealth for the Houston region and making it a global competitor in life science commercialization. The company is headquartered in Houston, TX.

Sinopsys Surgical, Inc. provides medical devices and instruments to evaluate potential new surgical procedures for the treatment of sinusitis. It offers instruments for surgical procedure for the lacrimal glands. The company was founded by Harry Ross in 2011 and is headquartered in Boulder, CO.

Mercury Partners Management LLC (Mercury Partners) is a venture capital subsidiary of Threshold Ventures Inc. founded in 2005 by Dan Watkins and Blair Garrou. The firm is headquartered in Houston, Texas.

Glycos Biotechnologies, Inc. operates as a biochemical company which commercializes sustainable chemicals made from renewable feed stocks. It offers Lactic acid, Isoprene and Butadiene products. It also offers metabolic engineering and process development technology solutions. The company was founded by Ramon Y. Gonzalez and Syed Shams Yazdani in February 2007 and is headquartered in Houston, TX.

Aclaris Life Sciences, Inc. operates as a technology-based company which focuses on rational drug design to identify novel drugs for cancer and chronic inflammatory diseases. It also engages in design and development of kinase inhibitors that target key enzymes involved in the regulation of cancer growth, survival and metastasis in modulations of chronic inflammation. The company was founded by Joseph B. Monahan, Gabriel Mbalaviele and Shaun R. Selness in 2010 and is headquartered in St. Louis, MO.

BioHouston, Inc. engages in life science and biotechnology commercialization. The firm's mission is to create an environment that will stimulate technology transfer and research commercialization, thereby generating economic wealth for the Houston region and making it a global competitor in life science commercialization. The company is headquartered in Houston, TX.

DNAtrix, Inc. operates as a biotech company which focuses on the development of oncolytic viruses for cancer. The firm’s offers DNX-2401 product which is an oncolytic virus designed specifically for treating Glioblastoma. It also works to expand its platform technology for treating other cancers, including ovarian, prostate and pancreatic cancer indications. The company was founded in 2005 by Francis Patrick McCormick, Alfred Yung, Charles Conrad, Cande Gomez-Manzano and Juan Fueyo and is headquartered in Houston, TX.

DNAtrix, Inc. operates as a biotech company which focuses on the development of oncolytic viruses for cancer. The firm’s offers DNX-2401 product which is an oncolytic virus designed specifically for treating Glioblastoma. It also works to expand its platform technology for treating other cancers, including ovarian, prostate and pancreatic cancer indications. The company was founded in 2005 by Francis Patrick McCormick, Alfred Yung, Charles Conrad, Cande Gomez-Manzano and Juan Fueyo and is headquartered in Houston, TX.

Mercury Partners Management LLC (Mercury Partners) is a venture capital subsidiary of Threshold Ventures Inc. founded in 2005 by Dan Watkins and Blair Garrou. The firm is headquartered in Houston, Texas.

Mercury Partners Management LLC (Mercury Partners) is a venture capital subsidiary of Threshold Ventures Inc. founded in 2005 by Dan Watkins and Blair Garrou. The firm is headquartered in Houston, Texas.

Aclaris Life Sciences, Inc. operates as a technology-based company which focuses on rational drug design to identify novel drugs for cancer and chronic inflammatory diseases. It also engages in design and development of kinase inhibitors that target key enzymes involved in the regulation of cancer growth, survival and metastasis in modulations of chronic inflammation. The company was founded by Joseph B. Monahan, Gabriel Mbalaviele and Shaun R. Selness in 2010 and is headquartered in St. Louis, MO.

Mercury Partners Management LLC (Mercury Partners) is a venture capital subsidiary of Threshold Ventures Inc. founded in 2005 by Dan Watkins and Blair Garrou. The firm is headquartered in Houston, Texas.

DNAtrix, Inc. operates as a biotech company which focuses on the development of oncolytic viruses for cancer. The firm’s offers DNX-2401 product which is an oncolytic virus designed specifically for treating Glioblastoma. It also works to expand its platform technology for treating other cancers, including ovarian, prostate and pancreatic cancer indications. The company was founded in 2005 by Francis Patrick McCormick, Alfred Yung, Charles Conrad, Cande Gomez-Manzano and Juan Fueyo and is headquartered in Houston, TX.

BioHouston, Inc. engages in life science and biotechnology commercialization. The firm's mission is to create an environment that will stimulate technology transfer and research commercialization, thereby generating economic wealth for the Houston region and making it a global competitor in life science commercialization. The company is headquartered in Houston, TX.

Sinopsys Surgical, Inc. provides medical devices and instruments to evaluate potential new surgical procedures for the treatment of sinusitis. It offers instruments for surgical procedure for the lacrimal glands. The company was founded by Harry Ross in 2011 and is headquartered in Boulder, CO.

BioHouston, Inc. engages in life science and biotechnology commercialization. The firm's mission is to create an environment that will stimulate technology transfer and research commercialization, thereby generating economic wealth for the Houston region and making it a global competitor in life science commercialization. The company is headquartered in Houston, TX.

Sinopsys Surgical, Inc. provides medical devices and instruments to evaluate potential new surgical procedures for the treatment of sinusitis. It offers instruments for surgical procedure for the lacrimal glands. The company was founded by Harry Ross in 2011 and is headquartered in Boulder, CO.

Glycos Biotechnologies, Inc. operates as a biochemical company which commercializes sustainable chemicals made from renewable feed stocks. It offers Lactic acid, Isoprene and Butadiene products. It also offers metabolic engineering and process development technology solutions. The company was founded by Ramon Y. Gonzalez and Syed Shams Yazdani in February 2007 and is headquartered in Houston, TX.

BioHouston, Inc. engages in life science and biotechnology commercialization. The firm's mission is to create an environment that will stimulate technology transfer and research commercialization, thereby generating economic wealth for the Houston region and making it a global competitor in life science commercialization. The company is headquartered in Houston, TX.

Mercury Partners Management LLC (Mercury Partners) is a venture capital subsidiary of Threshold Ventures Inc. founded in 2005 by Dan Watkins and Blair Garrou. The firm is headquartered in Houston, Texas.